Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments

Ended Project Grant Awarded Last action

Award ID
R44ES035336
Recipient
Awarding agency
Obligated
$2,730,996

Award facts

Assistance listing
93.113 Environmental Health
Completion date
Originally
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Description

Abstract
Mutations are heritable changes in the cellular genome and are key events in the induction of cancer, birth defects, and neurological diseases. The lack of a mutagenicity bioassay in human cells is a major data GAP in the genetic toxicology test battery used by regulatory agencies for hazard identification and quantitative risk assessments. Scitovation is developing a new approach methodologies (nams) combining human cells and error corrected next generation sequencing as an in vitro alternative to current regulatory mammalian cell mutagenicity assessment using rodent cell lines, and as an in vitro alternative to in vivo mutation assays.

Transactions

Action Obligated Date
Amendment $0
Amendment $910,332
Amendment $910,332
Original award $910,332

Quick answers

Who received award R44ES035336?

R44ES035336 was awarded to Scitovation, LLC by National Institute of Environmental Health Sciences (National Institutes of Health) on May 23, 2023.

How much is award R44ES035336 worth?

$2,730,996 has been obligated on R44ES035336.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award